Interaction between clopidogrel and proton-pump inhibitors.

about

Platelet reactivity tests for assessing antiplatelet drug response: what the clinician needs to know.

P2860

Q38132252-B2975D13-F98B-46A4-AB53-C0FD49581F61

P2860

Interaction between clopidogrel and proton-pump inhibitors.

Item

http://www.wikidata.org/entity/Q42723622

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Interaction between clopidogrel and proton-pump inhibitors.

@en

Interaction between clopidogrel and proton-pump inhibitors.

@nl

type

Item

label

Interaction between clopidogrel and proton-pump inhibitors.

@en

Interaction between clopidogrel and proton-pump inhibitors.

@nl

prefLabel

Interaction between clopidogrel and proton-pump inhibitors.

@en

Interaction between clopidogrel and proton-pump inhibitors.

@nl

P1476

Interaction between clopidogrel and proton-pump inhibitors.

@en

P2093

Lauren Czosnowski

http://www.w3.org/2001/XMLSchema#string

Lauren K McCluggage

http://www.w3.org/2001/XMLSchema#string

Sarah Spinler

http://www.w3.org/2001/XMLSchema#string

Victor Ly

http://www.w3.org/2001/XMLSchema#string

P2860

Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives

Cytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stents.

Review article: cytochrome P450 and the metabolism of proton pump inhibitors--emphasis on rabeprazole.

Influence of omeprazole on the antiplatelet action of clopidogrel associated with aspirin: the randomized, double-blind OCLA (Omeprazole CLopidogrel Aspirin) study.

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Genetic determinants of response to clopidogrel and cardiovascular events.

Cytochrome p-450 polymorphisms and response to clopidogrel.

Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study.

P304

89-102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/ECP.09.58

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22111535

http://www.w3.org/2001/XMLSchema#string

P921

clopidogrel

Interaction between clopidogrel and proton-pump inhibitors.

about

P2860

P2860

Interaction between clopidogrel and proton-pump inhibitors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921